NTX 010
N/A
Report date: 2024/04/18 14:32:45
Base Information
Drug NameNTX 010
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[8]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesNeotropix IncNational Cancer Institute
Active Indications
Inactive Indications +[7]
Other Information
ATC CodeN/A
Related LinksN/A